首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of pharmaceutics and biopharmaceutics

缩写:EUR J PHARM BIOPHARM

ISSN:0939-6411

e-ISSN:1873-3441

IF/分区:4.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引4382
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ke Wang,Qilong Wang,Michael Adu-Frimpong et al. Ke Wang et al.
Bisdemethoxycurcumin (BDMC) exhibits anti-inflammatory, antioxidant, and antitumor properties. Nonetheless, there is currently no published evidence regarding its efficacy in the management of idiopathic pulmonary fibrosis (IPF). Low solubi...
Salma A Fereig,John Youshia,Ghada M El-Zaafarany et al. Salma A Fereig et al.
Background: Chemotherapy-induced alopecia (CIA) causes significant psychological distress, prompting the need for effective prophylactic or therapeutic interventions. Phenobarbital, a potential agent for re-purposing towa...
Abdelrahman A Elfarouny,Yusuf A Haggag,Ebtessam A Essa et al. Abdelrahman A Elfarouny et al.
Simvastatin/Ezetimibe (SIM/EZE) is a widely prescribed hypolipidemic drug combination that provides substantial cardiovascular protection, particularly in high-risk patients. However, its poor dissolution and extensive first-pass metabolism...
Kathrin Schorr,Johannes Konrad,Jan Birringer et al. Kathrin Schorr et al.
Nanoparticles are frequently designed as carriers to mediate the active transport of their cargo to the site of action, thereby serving as effector particles. However, after their in vivo administration, they become quickly recognized by im...
Maria Lteif,Sara Abratanska,Isabelle Turbica et al. Maria Lteif et al.
Immunogenicity is a major challenge to the development of biotherapeutics, and it is now well admitted that aggregation of therapeutic antibodies contributes to inducing an immunogenic response. The aim of this work was to investigate the T...
Caden Maners,Anthony J Kyser,Davis Verhoeven et al. Caden Maners et al.
Catheter-associated urinary tract infections (CAUTI) represent a large healthcare burden, accounting for a substantial portion of hospital-acquired infections in the United States. Solutions such as intermittent catheterization and catheter...
Sahar Marami,Mohammad Hossein Tavakoli,Abdolazim Sedighi Pashaki et al. Sahar Marami et al.
Magnetic nanoparticle hyperthermia (MNP-HT) has emerged as a promising non-invasive technique for targeted cancer therapy. This study presents a comprehensive computational analysis of the influence of urine volume on the efficacy of MNP-HT...
Chengke Ding,Huiting Li,Pengbo Han et al. Chengke Ding et al.
Tyrosinase-related protein 2 (Trp2) peptide-based vaccines hold great promise for melanoma immunotherapy, however, their application is often limited by inefficient antigen delivery, inadequate dendritic cell (DC)-mediated immune activation...
Mohammad Qutub,Amol Tatode,Tanvi Premchandani et al. Mohammad Qutub et al.
Volumetric muscle loss (VML) results in permanent functional deficits for which current therapeutic strategies are insufficient. We hypothesized that an injectable, thermoresponsive hydrogel enabling localized delivery of agmatine sulfate (...
Paula Gonzalez-Fernandez,Luca Morici,Luca Simula et al. Paula Gonzalez-Fernandez et al.
Osteoarthritis (OA) is the most common joint disease worldwide causing cartilage loss, inflammation and pain. Lorecivivint (LOR) is a new disease-modifying osteoarthritis drug (DMOAD) that targets the Wnt pathway to improve cartilage regene...